T2 Biosystms Stock Buy Hold or Sell Recommendation

Name: T2 Biosystms: Strong Sell
Start: 2023-03-27
End: 2023-03-27
Location: T2 Biosystms

TTOO Stock

USD 0.50 0.04 7.41%

Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding T2 Biosystms is 'Strong Sell'. Macroaxis provides T2 Biosystms buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding TTOO positions. The advice algorithm takes into account all of T2 Biosystms' available fundamental, technical, and predictive indicators you will find on this site.

The advice is provided from T2 Biosystms' buy-and-hold perspective. Check out T2 Biosystms Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in T2 Biosystms Stock please use our How to Invest in T2 Biosystms guide.We conduct extensive research on individual companies such as T2 Biosystms and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards T2 Biosystms.

Execute T2 Biosystms Buy or Sell Advice

The T2 Biosystms recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on T2 Biosystms. Macroaxis does not own or have any residual interests in T2 Biosystms or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute T2 Biosystms' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice

Strong Sell

Volatility	Out of control	Details
Hype Condition	Over hyped	Details
Current Valuation	Undervalued	Details
Odds of Distress	High	Details
Economic Sensitivity	Hyperactively responds to market trends	Details
Analyst Consensus	Hold	Details
Financial Strenth (F Score)	Healthy	Details
Financial Leverage	Inapplicable	Details
Reporting Quality (M-Score)	Unlikely Manipulator	Details

For the selected time horizon T2 Biosystms has a Mean Deviation of 4.8, Standard Deviation of 7.04 and Variance of 49.53

We provide trade recommendation to complement the latest expert consensus on T2 Biosystms. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at this moment. To make sure T2 Biosystms is not overpriced, please validate all T2 Biosystms fundamentals, including its shares owned by insiders, total debt, retained earnings, as well as the relationship between the revenue and earnings per share . As T2 Biosystms appears to be a penny stock we also recommend to double-check its price to earning numbers.

T2 Biosystms Trading Alerts and Improvement Suggestions

	T2 Biosystms generated a negative expected return over the last 90 days
	T2 Biosystms has high historical volatility and very poor performance
	T2 Biosystms has some characteristics of a very speculative penny stock
	T2 Biosystms has a very high chance of going through financial distress in the upcoming years
	The company reported the previous year's revenue of 28.06 M. Net Loss for the year was (49.24 M) with loss before overhead, payroll, taxes, and interest of (24.77 M).
	T2 Biosystms currently holds about 13.21 M in cash with (38.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.87, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
	Latest headline from kalkinemedia.com: T2 Biosystems Affirms Plans To Add Candida Auris Detection To The FDA-Cleared T2candida Panel

Invested Capital Average Invested Capital

T2 Biosystms Returns Distribution Density

The distribution of T2 Biosystms' historical returns is an attempt to chart the uncertainty of T2 Biosystms' future price movements. The chart of the probability distribution of T2 Biosystms stock daily returns describes the distribution of returns around its average expected value. We use T2 Biosystms price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of T2 Biosystms returns is essential to provide solid investment advice for T2 Biosystms.

Mean Return	-1.04	Value At Risk	-9.68
Potential Upside	7.60	Standard Deviation	7.04

Return Density

Distribution

Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of T2 Biosystms historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

T2 Biosystms Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as T2 Biosystms is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading T2 Biosystms backward and forwards among themselves. T2 Biosystms' institutional investor refers to the entity that pools money to purchase T2 Biosystms' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.

	Last Transaction	Type	Shares	Value
Altium Capital Management Lp	2022-09-30	Common Shares	2.8 M	321 K
Vanguard Group Inc	2022-12-31	Common Shares	175.4 K	249.1 K
Principal Financial Group Inc	2022-03-31	Common Shares	177.8 K	93 K
Gagnon Securities Llc	2022-09-30	Common Shares	766.3 K	87 K
Bank Of New York Mellon Corp	2022-12-31	Common Shares	60.3 K	85.6 K
Millennium Management Llc	2022-06-30	Common Shares	453.7 K	73 K
Blackrock Inc	2022-12-31	Common Shares	51.3 K	72.8 K
Mcadam Llc	2022-12-31	Common Shares	113.2 K	58 K
Susquehanna International Group Llp	2022-12-31	Call Options	39.4 K	55.9 K
Ifp Advisors Inc	2022-12-31	Common Shares	6.4 K	55 K
Virtu Financial Llc	2022-06-30	Common Shares	323.4 K	52 K

Note, although T2 Biosystms' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

T2 Biosystms Cash Flow Accounts

	2018	2019	2020	2021	2022	2023 (projected)
Capital Expenditure	(593 K)	(761 K)	(800 K)	(460 K)	(529 K)	(570.76 K)
Depreciation Amortization and Accretion	2.45 M	3.64 M	3.16 M	2.54 M	2.92 M	2.71 M
Net Cash Flow or Change in Cash and Cash Equivalents	8.93 M	(39.77 M)	6.13 M	6.45 M	5.81 M	6.27 M
Issuance Purchase of Equity Shares	51.2 M	7.23 M	85.61 M	20.54 M	23.62 M	28.56 M
Issuance Repayment of Debt Securities	11.4 M	(1.19 M)	(1.55 M)	(882 K)	(793.8 K)	(814.69 K)
Net Cash Flow from Financing	49.66 M	6.35 M	85.61 M	20.54 M	23.62 M	35.3 M
Net Cash Flow from Investing	(593 K)	(761 K)	(36.26 M)	24.79 M	28.51 M	30.76 M
Net Cash Flow from Operations	(40.14 M)	(45.36 M)	(43.22 M)	(38.87 M)	(34.99 M)	(37.75 M)
Share Based Compensation	9.9 M	5.46 M	3.91 M	7.09 M	8.15 M	6.77 M

Backtest T2 Biosystms

T2 Biosystms Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to T2 Biosystms or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that T2 Biosystms' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a T2 Biosystms stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.

α	Alpha over NYSE Composite	-1	Details
β	Beta against NYSE Composite	2.06	Details
σ	Overall volatility	7.12	Details
Ir	Information ratio	-0.15	Details

T2 Biosystms Volatility Alert

T2 Biosystms is displaying above-average volatility over the selected time horizon. Investors should scrutinize T2 Biosystms independently to ensure intended market timing strategies are aligned with expectations about T2 Biosystms volatility. T2 Biosystms is a potential penny stock. Although T2 Biosystms may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in T2 Biosystms. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on T2 Biosystms instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.

T2 Biosystms Fundamentals Vs Peers

Comparing T2 Biosystms' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze T2 Biosystms' direct or indirect competition across all of the common fundamentals between T2 Biosystms and the related equities. This way, we can detect undervalued stocks with similar characteristics as T2 Biosystms or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of T2 Biosystms' fundamental indicators could also be used in its relative valuation, which is a method of valuing T2 Biosystms by comparing valuation metrics with those of similar companies.

Better Than Average

Worse Than Average

Compare T2 Biosystms to competition

Fundamentals	T2 Biosystms	Peer Average
Return On Equity	(6.22) %	(0.31) %
Return On Asset	(0.73) %	(0.14) %
Profit Margin	(2.79) %	(1.27) %
Operating Margin	(2.49) %	(5.51) %
Current Valuation	49.08 M	16.62 B
Shares Outstanding	16.73 M	571.82 M
Shares Owned by Insiders	2.18 %	10.09 %
Shares Owned by Institutions	18.46 %	39.21 %
Number of Shares Shorted	524.31 K	4.71 M
Price to Earning	(2.04) X	28.72 X
Price to Book	14.50 X	9.51 X
Price to Sales	0.40 X	11.42 X
Revenue	28.06 M	9.43 B
Gross Profit	(24.77 M)	27.38 B
EBITDA	(40.12 M)	3.9 B
Net Income	(49.24 M)	570.98 M
Cash and Equivalents	13.21 M	2.7 B
Cash per Share	1.87 X	5.01 X
Total Debt	47.79 M	5.32 B
Debt to Equity	6.64 %	48.70 %
Current Ratio	1.87 X	2.16 X
Book Value Per Share	(5.18) X	1.93 K
Cash Flow from Operations	(38.87 M)	971.22 M
Short Ratio	0.61 X	4.00 X
Earnings Per Share	(12.66) X	3.12 X
Target Price	0.57
Number of Employees	160	18.84 K
Beta	0.32	-0.15
Market Capitalization	8.37 M	19.03 B
Total Asset	60.54 M	29.47 B
Retained Earnings	(184.73 M)	9.33 B
Working Capital	59.25 M	1.48 B
Current Asset	77.78 M	9.34 B

Exercise or conversion by Sperzel John J Iii of 16000 shares of T2 Biosystms subject to Rule 16b-3 [view details]

T2 Biosystms Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as T2 Biosystms . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

	Accumulation Distribution	30976.47
	Daily Balance Of Power	(1.33)
	Rate Of Daily Change	0.93
	Day Median Price	0.5
	Day Typical Price	0.5
	Price Action Indicator	(0.015)

About T2 Biosystms Buy or Sell Advice

When is the right time to buy or sell T2 Biosystms? Buying financial instruments such as T2 Biosystms Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.

Please read more on our stock advisor page.

	2020	2021	2022	2023 (projected)
Receivables	5.1 M	5.13 M	4.62 M	4.99 M
Inventories	3.64 M	3.91 M	3.52 M	3.8 M

Receivables Inventories

Use Investing Ideas to Build Portfolios

In addition to having T2 Biosystms in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Latest Gainers Thematic Idea Now

Latest Gainers

Dynamically computed list of top equities currently sorted across major exchanges. The Latest Gainers theme has 81 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Latest Gainers Theme or any other thematic opportunities.

View All Next

Launch

Check out T2 Biosystms Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in T2 Biosystms Stock please use our How to Invest in T2 Biosystms guide. You can also try Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for analysis

When running T2 Biosystms price analysis, check to measure T2 Biosystms' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy T2 Biosystms is operating at the current time. Most of T2 Biosystms' value examination focuses on studying past and present price action to predict the probability of T2 Biosystms' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move T2 Biosystms' price. Additionally, you may evaluate how the addition of T2 Biosystms to your portfolios can decrease your overall portfolio volatility.

	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Share Portfolio Track or share privately all of your investments from the convenience of any device
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Piotroski F Score Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated

Is T2 Biosystms' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of T2 Biosystms. If investors know T2 Biosystms will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about T2 Biosystms listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(12.66)

Revenue Per Share

4.373

Quarterly Revenue Growth

(0.21)

Return On Assets

(0.73)

Return On Equity

(6.22)

The market value of T2 Biosystms is measured differently than its book value, which is the value of T2 Biosystms that is recorded on the company's balance sheet. Investors also form their own opinion of T2 Biosystms' value that differs from its market value or its book value, called intrinsic value, which is T2 Biosystms' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because T2 Biosystms' market value can be influenced by many factors that don't directly affect T2 Biosystms' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between T2 Biosystms' value and its price as these two are different measures arrived at by different means. Investors typically determine T2 Biosystms value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, T2 Biosystms' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2023 Macroaxis LLC

T2 Biosystms Stock Buy Hold or Sell Recommendation

Execute T2 Biosystms Buy or Sell Advice

Time Horizon

Risk Tolerance

Volatility

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Financial Strenth (F Score)

Financial Leverage

Reporting Quality (M-Score)

T2 Biosystms Trading Alerts and Improvement Suggestions

T2 Biosystms Returns Distribution Density

T2 Biosystms Stock Institutional Investors

T2 Biosystms Cash Flow Accounts

T2 Biosystms Greeks

T2 Biosystms Volatility Alert

T2 Biosystms Fundamentals Vs Peers

T2 Biosystms Market Momentum

About T2 Biosystms Buy or Sell Advice

Use Investing Ideas to Build Portfolios

Did You Try This Idea?

Run Latest Gainers Thematic Idea Now

Latest Gainers

Complementary Tools for analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY